Asthma may Become History in Next Five Years After Potential Drug Breakthrough

Drugs known as calcilytics is very effective in manipulating the calcium sensing receptor that causes asthma and reverses all symptoms of the condition.

Asthma maybe cured in the next five years after drug breakthrough, reveals a new study by Cardiff University researchers.

Researchers working in collaboration with scientists at King’s College London and the Mayo Clinic (USA), described the previously unproven role of the calcium sensing receptor (CaSR) in causing asthma, a disease which affects 300 million people worldwide.

Study Sheds New Light on Asthma and Chronic Obstructive Pulmonary Disease
People with respiratory problems suffer from too much mucus production. Scientists are now analyzing the role of a protein that causes mucus build-up.

The team used mouse models of asthma and human airway tissue from asthmatic and non-asthmatic people to reach their findings.

Crucially, the paper highlighted the effectiveness of a class of drugs known as calcilytics in manipulating CaSR to reverse all symptoms associated with the condition. These symptoms include airway narrowing, airway twitchiness and inflammation, all of which contribute to increased breathing difficulty.

Professor Daniela Riccardi, from Cardiff University School of Biosciences, said that their paper showed how these triggers release chemicals that activate CaSR in airway tissue and drive asthma symptoms like airway twitchiness, inflammation, and narrowing. Using calcilytics, nebulized directly into the lungs, they showed that it was possible to deactivate CaSR and prevent all of these symptoms, Riccardi further added.

Chewable Tablets For Asthma and Allergies Get FDA Approval
Montelukast Sodium chewable tablets formulated by Jubilant Life Sciences relieve symptoms of seasonal allergies and treats asthma.

According to Cardiff University Professor Paul Kemp, who co-authored the study, the identification of CaSR in airway tissue means that the potential for treatment of other inflammatory lung diseases beyond asthma was immense.

These include chronic obstructive pulmonary disease (COPD) and chronic bronchitis, for which currently there exists no cure. It is predicted that by 2020 these diseases will be the third biggest killers worldwide.

Specific Protein Linked to Development of Asthma Paves Way for New Therapy
Scientists have linked a specific protein to the development of post-viral infection asthma, which is the first step in generating a novel type of asthma therapy designed to prevent its development in young children.

The study is published in Science Translational Medicine journal.

Source-ANI

Preventing Development of Asthma With Psychedelic Drug
A psychedelic drug, (R)-DOI, may help prevent asthma development. Research led by Charles Nicholas has found that this drug prevents the development of allergic asthma in a mouse model.